Cell-based Therapies: A Maturing Market Poised for Growth
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Cell-based Therapies: A Maturing Market Poised for Growth
Market Insight: by Dr. Oded Ben-Joseph and Dr. Echoe Bouta
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Recent advances in cell-based therapy technology and FDA approvals have demonstrated the feasibility of of treating difficult diseases. Given the progress, we examined recent market dynamics in a 3.5-year period starting in January 2015 by analyzing clinical trials, financing events, M&As and IPOs to assess the overall activity of the sector and interest by venture capitalists and strategic players
Events
Cambridge in America — University of Cambridge Alumni in Life Sciences
Tuesday, July 23 6:00-7:30pm Cost: This event is hosted by Dr. Oded Ben-Joseph (Darwin 1988), Managing Director, Outcome Capital, LLC, and is free to attend with prior RSVP. Outcome Capital, LLC 99 High Street, Suite 2900 Boston, MA RSVP to Megan Cokely at megan@cantab.org Cambridge in America’s Boston Regional Committee invites you to another exclusive event for […]
Read MoreNews
Outcome Capital Secures Growth Capital for Whisker Labs
Outcome Capital Secures Growth Capital for Whisker Labs November 26, 2019, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in the technology and life sciences space, is pleased to announce that Whisker Labs, Inc. (the “Company”) has secured growth capital from State Farm Ventures and Ferguson Ventures along with […]
Read MoreContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2019. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy
